News
Novo Nordisk A/S surged on expectations that some competition for its blockbuster obesity shot Wegovy will subside, paving ...
He’s a 30-year-old systems engineer who isn’t taking no for an answer when it comes to access to this life-changing weight ...
Idaho, Kansas and Missouri filed their complaint after the Supreme Court preserved access to mifepristone last year.
Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...
Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...
NAD+ is considered beneficial for various cellular reactions that benefit your healthspan. It may also support more ...
Domestic manufacturers are appealing to government regulators to take more proactive steps to ensure the country will be ...
The FDA has released its report on the 2023 actions of its Core Outbreak Response and Evaluation network. The network’s ...
The FDA is stepping up its unannounced inspections of foreign manufacturing facilities. In a statement about the increase in inspections, the Food and ...
Amid a federal push to phase-out artificial food dyes that are popular in things like cereal, candy and yogurt, some health ...
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results